Clinical trials
Diabetes Mellitus Risk clinical trials
Below are recruiting diabetes mellitus risk clinical trials, each written for real people, not researchers. We’re tracking 206 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07269405Enrolling by invitation
Study to prevent high blood sugar in women with past gestational diabetes
This trial tests a program to help women who had diabetes during pregnancy and now have extra risk factors. It aims to prevent blood sugar problems after childbirth. You would join in the first months after delivery to get support and see if your blood sugar stays healthy.
ShatinAges 18–50 - NCT06880835Recruiting
Inhaled insulin vs injected insulin for exercise blood sugar drops in type 1 diabetes
This trial tests whether a new inhaled insulin (Technosphere) causes fewer low blood sugar episodes during exercise compared to standard injected insulin in people with type 1 diabetes who use an automated insulin pump. It may help you avoid hypoglycemia while staying active.
Louisville, KentuckyAges 18–65 - NCT03568630Recruiting
Blood tests to study early pancreatic cancer risk
This study looks at blood “markers” to find early signs or higher risk for pancreatic cancer. You may join if you have certain risk factors (like new diabetes, pancreatic cysts/pancreatitis, or a strong family history) and can come to Omaha for blood draws twice a year.
Omaha, NebraskaAges 19 years+ - NCT03878706Recruiting
Testing diabetes medicines on heart risk and heart failure
This trial studies how diabetes medicines (GLP-1 and SGLT2, alone or together) affect the heart in people with type 2 diabetes who are at higher cardiovascular risk and have heart failure with preserved pumping function. It may help find safer or more effective ways to reduce heart problems.
Athens, AtticaAges 45–80 - NCT05740514Recruiting
Exercise program study for adults with type 1 diabetes
This study looks at how an exercise program affects “healthy outcomes” in people with type 1 diabetes. You might be invited if you are the right age, generally less active, and have a safe health profile for exercising.
Hamilton, OntarioAges 18–65 - NCT06293417Recruiting
Study of Ezefeno in patients with high cholesterol and type 2 diabetes
This trial tests a medicine called Ezefeno to see if it helps lower cholesterol in people with type 2 diabetes who are already on statins. It may be an option if you have high triglycerides and other heart risk factors.
SeoulAges 19 years+ - NCT06834204Enrolling by invitation
Better care coordination for cancer survivors
This study tests a program to improve communication between your cancer team and your regular doctor. If you have heart or diabetes risks and you're being treated for breast, prostate, bladder, or endometrial cancer, this trial may help coordinate your care.
New Brunswick, New JerseyAges 18 years+ - NCT06396871Recruiting
Blood cell study in metabolic diseases
This study looks at blood cells and factors in people with metabolic diseases like fatty liver, prediabetes, or type 2 diabetes. It aims to better understand these conditions by comparing them with healthy volunteers.
Dresden, SaxonyAges 18 years+ - NCT06449833RecruitingPhase 4
Henagliflozin for liver fat in diabetes and fatty liver
This study tests whether a medicine called henagliflozin can help reduce fat in the liver for people with type 2 diabetes and non-alcoholic fatty liver disease. It may help improve liver health and blood sugar control at the same time.
Guangzhou, GuangdongAges 18–75 - NCT06605508Recruiting
Stem cell injection for erectile dysfunction
This trial tests whether injecting stem cells or their byproducts can help men with erectile dysfunction who haven't responded well to standard treatments like Viagra. It aims to find a new option for improving sexual function.
Dubai, DubaiAges 30–75 - NCT06623396RecruitingPhase 1
CAR T-cell therapy for stomach and esophagus cancer
This trial tests a new treatment called CAR T-cell therapy that targets a protein called mesothelin found on some cancer cells. It is for people with advanced or recurrent cancer of the stomach or esophagus that has spread or come back after prior treatment.
Basking Ridge, New JerseyAges 18 years+ - NCT06695221Recruiting
Kefir trial for better health in Edmonton adults
This study tests if drinking kefir, a fermented dairy drink, can improve health in adults who are overweight or have high blood sugar or type 2 diabetes. It looks at how kefir might help with weight, blood sugar, and overall wellness.
Edmonton, AlbertaAges 24–70 - NCT06703788RecruitingPhase 1/Phase 2
Traditional Chinese Medicine Day Care for Metabolic Syndrome
This trial tests a day care program that combines traditional Chinese medicine with regular care for people with metabolic syndrome. It aims to see if this approach helps improve your health better than standard care alone.
TaoyuanAges 20–75 - NCT06752772Recruiting
Wearable health coaching for blood pressure and weight
This study tests a digital health coaching program that uses a smartwatch and smartphone to help people manage conditions like high blood pressure, pre-diabetes, or weight. It aims to see if wearable technology can improve your health with personalized coaching.
SingaporeAges 21–75 - NCT06796322Recruiting
Testing a needle-free blood sugar monitor
This study is testing a new device that measures blood sugar without a finger prick. It is open to healthy adults and people with type 2 diabetes, to see if the non-invasive meter works as well as standard blood tests.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06883682Recruiting
ECG sticker for checking blood sugar
This study tests a new way to measure blood sugar using an ECG (heart signal) sticker. It may help people with diabetes, chronic kidney disease, or those without diabetes monitor their glucose without finger sticks.
TaoyuanAges 18 years+ - NCT06938464Recruiting
Probiotics to prevent gestational diabetes in high-risk women
This study tests whether taking probiotics (friendly bacteria) during early pregnancy can help prevent gestational diabetes in women who are at higher risk for it.
Hangzhou, ZhejiangAges 18–50 - NCT06976164Recruiting
Reflexology for Gestational Diabetes
This study tests whether reflexology (a gentle foot massage therapy) can help manage blood sugar in pregnant women with gestational diabetes. It is for women who are in the middle to late stages of pregnancy and are otherwise healthy.
CairoAges 20–35 - NCT07106879Recruiting
Pre-screening for future metabolic and psychiatric studies
This study does not test a new treatment. It is a pre-screening program to see if you might qualify for future clinical trials on metabolic conditions (like diabetes or weight issues) or psychiatric health (like depression or anxiety). You will be asked some questions and may do some basic health checks to see which future trials could be a good fit for you.
Brooklyn, New YorkAges 18 years+ - NCT07270172Recruiting
Micronutrient study for type 1 diabetes complications
This study tests how a specific drug affects heart and kidney health in people with type 1 diabetes who already have some complications like kidney disease, heart problems, or obesity. It aims to find new ways to prevent further damage.
Aarhus NAges 40 years+ - NCT07296276Recruiting
Testing the CareSens Air 3 glucose monitor in type 1 diabetes
This study tests how accurate a new continuous glucose monitor (CGM) called CareSens Air 3 is for adults with type 1 diabetes. You would wear the sensor on your skin to track blood sugar levels, and it may help you manage your diabetes more easily.
Escondido, CaliforniaAges 18–65 - NCT07314684RecruitingPhase 4
Semaglutide's effect on inflammation in type 2 diabetes
This study tests whether the diabetes medication semaglutide can reduce inflammation and improve blood vessel health in people with type 2 diabetes who have no significant heart artery blockages. If you have diabetes and are at moderate to high heart risk but haven't had heart problems, this could help understand the medicine's extra benefits beyond blood sugar control.
Caserta, CasertaAges 18–85 - NCT07329647Recruiting
Brain nutrition study for cognitive decline
This trial tests whether a nitrate-rich food supplement can improve blood flow in the brain and help thinking and memory. It is for people with small vessel disease in the brain or diabetes who are at risk for cognitive decline.
CoimbraAges 18 years+ - NCT07385547RecruitingPhase 1
Kidney function and drug levels study
This study looks at how different levels of kidney function affect the amount of a medication in the body. It may help doctors decide on the right dose for people with kidney problems.
Miami, FloridaAges 18–80
Hear when a new Diabetes Mellitus Risk trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes mellitus risk?
- Yes. Clin2 currently lists 206 recruiting diabetes mellitus risk studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes mellitus risk trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes mellitus risk trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.